Who are we ? Episode #8 Marie-Julie Guichard

Who are we ? Episode #8 Marie-Julie Guichard

Through this mini-series of articles, we want to present you our whole team and skills of each.

  • Marie-Julie, can you introduce yourself briefly ?

I am in charge of Op2Lysis translational studies and regulatory affairs. Chemist with a Master 2 in pharmaceutical and biomedical engineering, I pursued my education with a PhD and I graduated from Université catholique de Louvain (Brussels, Belgium) in April 2018. During my PhD, I worked on the development of an innovative mucolytic agent for Cystic Fibrosis. I was fully in charge of conception and execution of pre-clinical studies as well as of data interpretation. During my training, I also benefited from a US research experience. I worked in pharmaceutical development in a biotech company based in Cambridge, MA.

  • Why did you choose to join the Op2Lysis team?

I was very pleased to join Op2Lysis. The project is in all respects consistent with my education and my wish to be part of an innovative project responding to a major medical need. Moreover, the company values are in line with my vision of the professional environment in which I want to evolve.

  • What is the strength of the technology developed by Op2Lysis?

The strength of Op2Lysis is based on the multidisciplinary skills of each fellow. Our wide knowledge of hemorrhagic stroke, of our product as well as of innovative solutions for precise medical needs are the foundation of our project.

  • What is your personal contribution to Op2lysis?

I am in charge of the pre-clinical development of our product as well as of the regulatory activities related to its future registration.

My professional experiences helped me develop skills in project management and in pre-clinical studies. The diversity of fields I have dealt with allows me to quickly integrate and become invested in the aspects of the project entrusted to me.

About the author

Tiffany Le Carff administrator